Your browser is no longer supported. Please, upgrade your browser.
Settings
CBPO China Biologic Products Holdings, Inc. daily Stock Chart
CBPO [NASD]
China Biologic Products Holdings, Inc.
Index- P/E20.59 EPS (ttm)3.84 Insider Own14.08% Shs Outstand28.07M Perf Week-18.62%
Market Cap2.22B Forward P/E14.08 EPS next Y5.62 Insider Trans-0.19% Shs Float23.40M Perf Month-12.90%
Income105.30M PEG1.92 EPS next Q1.19 Inst Own80.40% Short Float5.59% Perf Quarter-24.19%
Sales344.90M P/S6.43 EPS this Y14.10% Inst Trans0.00% Short Ratio4.13 Perf Half Y-31.34%
Book/sh20.28 P/B3.90 EPS next Y13.36% ROA16.00% Target Price124.79 Perf Year-32.15%
Cash/sh- P/C- EPS next 5Y10.74% ROE21.10% 52W Range78.94 - 125.99 Perf YTD-26.47%
Dividend- P/FCF21.74 EPS past 5Y40.50% ROI25.70% 52W High-38.26% Beta1.76
Dividend %- Quick Ratio3.20 Sales past 5Y17.40% Gross Margin65.00% 52W Low-1.46% ATR3.45
Employees1799 Current Ratio5.20 Sales Q/Q-49.50% Oper. Margin40.90% RSI (14)28.10 Volatility6.97% 3.90%
OptionableYes Debt/Eq0.03 EPS Q/Q-46.40% Profit Margin30.50% Rel Volume1.22 Prev Close79.06
ShortableYes LT Debt/Eq0.00 EarningsNov 01 AMC Payout0.00% Avg Volume316.78K Price77.79
Recom1.80 SMA20-14.44% SMA50-15.40% SMA200-25.17% Volume250,322 Change-1.61%
May-30-17Initiated Goldman Neutral
Mar-01-16Downgrade Credit Suisse Outperform → Neutral
Oct-08-15Initiated Credit Suisse Outperform
Jul-09-15Initiated BofA/Merrill Buy $135
Jul-08-14Reiterated Aegis Capital Buy $50 → $55
Mar-14-14Initiated Oppenheimer Outperform $46
Nov-06-13Downgrade Aegis Capital Buy → Hold
Mar-14-13Reiterated Aegis Capital Buy $22 → $28
May-13-10Reiterated Brean Murray Buy $19 → $20
Mar-26-10Reiterated Brean Murray Buy $15 → $19
Oct-13-17 10:36AM  ETFs with exposure to China Biologic Products Holdings, Inc. : October 13, 2017 Capital Cube
08:36AM  China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : October 13, 2017 Capital Cube
08:00AM  China Biologic Products Announces Conference Call to Discuss TianXinFu Acquisition PR Newswire
Oct-12-17 08:30AM  China Biologic Agrees to Acquire TianXinFu from PWM PR Newswire -14.99%
Oct-09-17 08:30AM  China Biologic Receives Approval for Commercial Manufacturing of Human Fibrinogen PR Newswire
Oct-03-17 08:16AM  China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : October 3, 2017 Capital Cube
Sep-28-17 10:10AM  ETFs with exposure to China Biologic Products Holdings, Inc. : September 28, 2017 Capital Cube
Sep-27-17 09:04AM  China Biologic Products Holdings, Inc. :CBPO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 27, 2017 Capital Cube
Sep-12-17 08:07AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Sep-11-17 10:11AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Sep-08-17 10:26AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Sep-01-17 08:02AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Aug-31-17 08:08AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit +7.17%
Aug-30-17 08:03AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Aug-12-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Aug-10-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Aug-09-17 08:05AM  IHS Markit Score upgrades China Biologic Products Holdings Inc to 34 out of 100, despite ranking positively in only one IHS Markit category. Markit
07:00AM  Featured Company News MannKind and One Drop Announce Collaboration to Deliver a Unified Solution for Diabetes Patients ACCESSWIRE
Aug-04-17 02:36AM  China Biologic Products posts 2Q profit Associated Press
Aug-03-17 05:00AM  Investor Network: China Biologic Products, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-17 05:00PM  China Biologic Reports Financial Results for the Second Quarter of 2017 PR Newswire
Jul-25-17 03:44AM  Why China Biologic is the Best of China's Blood Plasma Stocks Barrons.com
Jul-24-17 05:50AM  Edited Transcript of CBPO earnings conference call or presentation 5-Aug-16 11:30am GMT Thomson Reuters StreetEvents
05:50AM  Edited Transcript of CBPO earnings conference call or presentation 24-Feb-17 12:30pm GMT Thomson Reuters StreetEvents
05:49AM  Edited Transcript of CBPO earnings conference call or presentation 7-May-15 11:30am GMT Thomson Reuters StreetEvents
Jul-19-17 08:00AM  China Biologic Products to Report Second Quarter of 2017 Financial Results PR Newswire
Jul-17-17 01:40PM  ETFs with exposure to China Biologic Products, Inc. : July 17, 2017 Capital Cube
Jul-06-17 01:47PM  ETFs with exposure to China Biologic Products, Inc. : July 6, 2017 Capital Cube
Jul-04-17 09:53AM  China Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : July 4, 2017 Capital Cube
Jun-22-17 03:29PM  ETFs with exposure to China Biologic Products, Inc. : June 22, 2017 Capital Cube
Jun-16-17 11:46AM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Capital Cube
Jun-09-17 02:12PM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : June 9, 2017 Capital Cube
Jun-08-17 08:24AM  China Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : June 8, 2017 Capital Cube -5.88%
May-19-17 04:05PM  China Biologic Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for 2017 Annual Meeting of Stockholders PR Newswire
May-08-17 09:27AM  Edited Transcript of CBPO earnings conference call or presentation 4-May-17 11:30am GMT Thomson Reuters StreetEvents
May-04-17 10:29PM  This Chinese Pharma Stock Has 20% Upside Barrons.com
07:05AM  Investor Network: China Biologic Products, Inc. to Host Earnings Call Accesswire
05:02AM  China Biologic Products posts 1Q profit Associated Press
May-03-17 04:45PM  China Biologic Reports Financial Results for the First Quarter of 2017 PR Newswire
Apr-21-17 08:00AM  China Biologic Products to Report First Quarter of 2017 Financial Results PR Newswire
Apr-12-17 01:21PM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : April 12, 2017 Capital Cube
Apr-11-17 08:17AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : April 11, 2017 Capital Cube
Apr-07-17 04:05PM  ETFs with exposure to China Biologic Products, Inc. : April 7, 2017 Capital Cube
Mar-02-17 10:06AM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017 Capital Cube
10:06AM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017
Mar-01-17 01:04PM  CHINA BIOLOGIC PRODUCTS, INC. Financials
Feb-24-17 01:22PM  Edited Transcript of CBPO earnings conference call or presentation 24-Feb-17 12:30pm GMT Thomson Reuters StreetEvents
Feb-23-17 07:53PM  China Biologic Products posts 4Q profit Associated Press
05:00PM  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 PR Newswire
04:57PM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 10-K, Annual Report
07:07AM  Q4 2016 China Biologic Products Inc Earnings Release - After Market Close
Feb-14-17 04:05PM  China Biologic Products to Report Fourth Quarter and Fiscal Year 2016 Financial Results PR Newswire
Jan-30-17 09:20AM  New Strong Sell Stocks for January 30th Zacks
Jan-27-17 01:34PM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : January 27, 2017 Capital Cube
01:34PM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : January 27, 2017
Jan-26-17 07:52AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : January 26, 2017 Capital Cube
07:52AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : January 26, 2017
Jan-18-17 08:01AM  New Strong Sell Stocks for January 18th
Jan-06-17 08:46AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  China Biologic to Build New Collection Station and New Branch Collection Facility in Shandong Province PR Newswire
Jan-04-17 08:47AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:30AM  China Biologic to Attend the 35th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-01-17 07:22AM  3 Biotech Stocks That Turned $10,000 Into Over $100,000 at Motley Fool
Dec-14-16 12:49PM  ETFs with exposure to China Biologic Products, Inc. : December 14, 2016
Dec-01-16 01:16PM  Should You Follow Hedge Funds Into China Biologic Products Inc (CBPO)? at Insider Monkey -5.12%
10:52AM  ETFs with exposure to China Biologic Products, Inc. : December 1, 2016
Nov-30-16 07:12AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : November 30, 2016
Nov-18-16 11:02AM  Should You Be Bullish on Tata Motors Limited (ADR) (TTM), China Biologic Products Inc (CBPO), & Two More? at Insider Monkey
Nov-08-16 08:46AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events
Nov-07-16 09:52AM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7, 2016
07:16AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : November 7, 2016
Nov-03-16 12:12PM  Edited Transcript of CBPO earnings conference call or presentation 3-Nov-16 11:30am GMT
05:07AM  China Biologic Products posts 3Q profit
Nov-02-16 05:00PM  China Biologic Reports Financial Results for the Third Quarter of 2016 PR Newswire
04:07PM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders
07:07AM  Q3 2016 China Biologic Products Inc Earnings Release - After Market Close
Oct-31-16 08:34AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events
Oct-27-16 08:15AM  Blog Coverage China Biologic Takes Full Ownership of Guizhou Taibang Accesswire
08:09AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : October 27, 2016
Oct-26-16 08:30AM  China Biologic Acquires Full Ownership of Guizhou Taibang PR Newswire
Oct-24-16 04:15PM  China Biologic Products to Report Third Quarter 2016 Financial Results PR Newswire
Oct-12-16 08:47AM  China Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : October 12, 2016
Oct-11-16 08:46AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  China Biologic Receives CFDA Clinical Trial Approval for Human Antithrombin III PR Newswire
Sep-20-16 08:38AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Sep-19-16 08:30AM  China Biologic Receives CFDA Clinical Trial Approval for Human Coagulation Factor IX PR Newswire
Sep-08-16 10:53AM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : September 8, 2016
Sep-07-16 08:10AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : September 7, 2016
Sep-06-16 10:09AM  ETFs with exposure to China Biologic Products, Inc. : September 6, 2016 +7.02%
Aug-31-16 06:51PM  Soros, Harvard Make Opposite Bets on China Plasma Company: Chart at Bloomberg
Aug-25-16 10:07AM  ETFs with exposure to China Biologic Products, Inc. : August 25, 2016
Aug-24-16 08:16AM  China Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : August 24, 2016
Aug-17-16 11:48AM  Massive Insider Selling at Northrop Grumman (NOC) and Chinese Biotech, While Insider Buying Observed at 3 Other Companies at Insider Monkey
Aug-16-16 08:31AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
Aug-15-16 08:30AM  China Biologic Announces Change to Board of Directors PR Newswire
Aug-11-16 07:26AM  Chinese Plasma Maker China Biologic a Solid Addition for a Portfolio
Aug-08-16 04:09PM  China Biologic Products, Inc.: Leads amongst peers with strong fundamentals -5.36%
12:25PM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016
Aug-05-16 12:08PM  Edited Transcript of CBPO earnings conference call or presentation 5-Aug-16 11:30am GMT +10.46%
06:48AM  China Biologic Products posts 2Q profit
China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin and immunoglobulin for intravenous injection products for original and secondary immunoglobulin deficiency, and auto-immune deficiency diseases; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing human hepatitis B immunoglobulin (pH4) for intravenous injection; human fibrinogen; immune globulin intravenous; human antithrombin III; human cytomegalovirus immunoglobulin; human coagulation factor IX; and human fibrin sealant products. The company sells its products directly, as well as through distributors. The company was formerly known as China Biologic Products, Inc. and changed its name to China Biologic Products Holdings, Inc. in July 2017. China Biologic Products Holdings, Inc. is headquartered in Beijing, the People's Republic of China.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Liu Zhijing CBPOCorporate Vice PresidentMay 09Option Exercise9.851,14211,2495,753May 10 04:30 PM
Liu Zhijing CBPOCorporate Vice PresidentMay 09Sale115.401,142131,7874,611May 10 04:30 PM
Liu Zhijing CBPOCorporate Vice PresidentMay 08Option Exercise9.856,35862,62610,969May 10 04:30 PM
Liu Zhijing CBPOCorporate Vice PresidentMay 08Sale116.686,358741,8514,611May 10 04:30 PM
Shao SeanDirectorMar 02Sale100.8016,0001,612,80020,000Mar 03 04:32 PM
Shao SeanDirectorMar 01Sale100.704,000402,80036,000Mar 03 04:32 PM
Gao DavidChief Executive OfficerMar 01Sale100.5754,0495,435,708395,347Mar 02 04:30 PM
Gao DavidChief Executive OfficerFeb 28Sale100.6962,6046,303,597449,396Mar 02 04:30 PM
Yeung AlbertDirectorDec 09Option Exercise10.4325,000260,65045,000Dec 12 06:50 AM